SCHEMBL4914580

SCHEMBL4914580

CC1(C)CCc2c(c3c([nH]c2=O)oc2c(NCCCN4CCCC4=O)ncnc23)C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 12/20 0.71
PDE4A P27815 11/20 0.71
PDE4D Q08499 11/20 0.71
ALDH1A1 P00352 6/20 0.47
KDM4E B2RXH2 5/20 0.47
HPGD P15428 3/20 0.47
HSD17B10 Q99714 3/20 0.47
LMNA P02545 2/20 0.47
MAPT P10636 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
RECQL P46063 1/20 0.46
POLB P06746 1/20 0.45
MAPK1 P28482 1/20 0.45
GFER P55789 1/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4921988 0.83 PDE4B (0.87) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4918255 0.83 PDE4B (1.00) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4913248 0.83 PDE4B (0.89) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4916906 0.82 PDE4B (0.87) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4916899 0.82 PDE4B (0.82) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4924655 0.82 PDE4B (0.80) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4757623 0.82 PDE4B (1.00) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4924082 0.80 PDE4B (0.79) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4923289 0.80 PDE4B (1.00) PDE4BPDE4APDE4DALDH1A1KDM4E
SCHEMBL4707052 0.77 PDE4B (0.82) PDE4BPDE4APDE4DALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221096-A1 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives LABORATORIOS ALMIRALL, S.A. (ES) 2008-09-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221096-A1 Pyrido[3' ,2':4,5]Furo[3,2-d]Pyrimidine Derivatives NR1H2, CBR3, NR4A1 PDE4B 4185/4885PDE4A 3960/4885PDE4D 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.